The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chub E.V.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia

Sivolobova G.F.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia

Netesov S.V.

Novosibirsk State University, Novosibirsk, Russia, 630090

Kochneva G.V.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia;
Novosibirsk state university, 630090, Novosibirsk, Russia

Recombinant variants of HCV in Siberia, Russia

Authors:

Chub E.V., Sivolobova G.F., Netesov S.V., Kochneva G.V.

More about the authors

Journal: Molecular Genetics, Microbiology and Virology. 2019;37(2): 64‑75

DOI: 10.17116/molgen20193702164

Read: 2256 times

Download PDF (RU)
Contact the author
Table of contents

RECOMBINANT VARIANTS OF HCV IN SIBERIA, RUSSIA
RECOMBINANT VARIANTS OF HCV IN SIBERIA, RUSSIA

To cite this article:

Chub EV, Sivolobova GF, Netesov SV, Kochneva GV. Recombinant variants of HCV in Siberia, Russia. Molecular Genetics, Microbiology and Virology. 2019;37(2):64‑75. (In Russ.)
https://doi.org/10.17116/molgen20193702164

Подписка 2026 Молекулярная генетика, микробиология и вирусология (Molecular Genetics, Microbiology and Virology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
DNA base editors are a promising tool to gene therapy of human viral infe­ctions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):4-8
Surgical treatment of intramedullary spinal cord tumors: a systematic review. Burdenko's Journal of Neurosurgery. 2025;(1):103-108
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Septum orbi­tale as a key element in lower blepharoplasty: evolution from classic to tissue-sparing techniques. Plastic Surgery and Aesthetic Medi­cine. 2025;(2-2):96-102
Infe­rior alveolar nerve injury and sensory reha­bilitation of the lower lip. Plastic Surgery and Aesthetic Medi­cine. 2025;(3):91-99
The exoskeleton of the hand in modern habi­litation and reha­bilitation (analytical review). Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(3):53-61
Community-acquired pneumonia in adults. Clinical guidelines 2024 (short version). Journal of Respiratory Medi­cine. 2025;(3):6-18
News in mole­cular biology. Digest of scientific publications. Issue 1. Labo­ratory Service. 2025;(3):5-7
Community-acquired pneumonia in adults. (Clinical practice guidelines, short version). Journal of Respiratory Medi­cine. 2025;(4):6-18
Abstract:

Abstract The review summarizes the results of a comprehensive multi-year molecular-epidemiological study of HCV (2001—2016) which started in Altai and Novosibirsk Regions when first eight cases of infection with the recombinant form of CRF01_1b2k HCV were detected. For all CRF01_1b2k isolates, the recombination site in the NS2 gene has been confirmed, that consistent with data for previously identified recombinants of the same form in other regions of Russia and the world. Analysis of the nucleotide sequences of the Core, E1, NS2 and NS5b gene fragments in genomes of eight recombinant 2k/1b isolates found in Siberia showed a close phylogenetic relationship between them, as well as 27 recombinants described to date in St. Petersburg, Azerbaijan, Armenia, Estonia, The Netherlands, Ireland, France and the United States. The level of homology between the genes of the HCV was as follows: for the Core gene — 97%, E1 — 94%, NS2 — 92%, NS5b — 96%. Phylogenetic analysis of genomes of recombinants showed the common origin of isolates of type 2k/1b and their wide circulation in the territory of Russia. Analysis of the 5’ part of the genome of recombinant isolates belonging to the 2k subtype showed that the closest isolates of the 2k subtype earlier, except for Russia, were also found in Moldova and Uzbekistan in 1996—2013. The incidence of recombinant isolates in the Siberian region is estimated at 1%. The molecular clock method has shown that the most probable time for the appearance of the recombinant form CRF01_1b2k is in the interval 1957—1970.

Keywords:

review
HCV
recombinant
form CRF01_1b2k
phylogenetic analysis
recombination point

Authors:

Chub E.V.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia

Sivolobova G.F.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia

Netesov S.V.

Novosibirsk State University, Novosibirsk, Russia, 630090

Kochneva G.V.

State Research Center of Virology and Biotechnology «Vector», 630559, Koltsovo, Russia;
Novosibirsk state university, 630090, Novosibirsk, Russia

Close metadata

References:

  1. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318-327.
  2. Yun Z, Lara C, Johansson B, Lorenzana de Rivera I, Sönnerborg AJ. Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences. Med Virol. 1996;49(3):155-160.
  3. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection. 2000;28(1):21-25.
  4. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol. 2002;4(76):4034-4043.
  5. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol. 2007;81(8):3693-3703.
  6. González-Candelas F, López-Labrador FX, Bracho MA. Recombination in hepatitis C virus. Viruses. 2011;3(10):2006-2024.
  7. Chub EV, Kochneva GV, Granitov VM, Netesov SV. Recombinants of hepatitis C virus type 2k/1b in the population of the Altai region. Infectious Diseases. 2007;5(4):5-11. (In Russ.)
  8. Raghwani J, Thomas XV, Koekkoek SM, Schinkel J, Molenkamp R, van de Laar TJ, et al. Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. J Virol. 2012;86(4):2212-2220.
  9. Demetriou VL, de Vijver D, Kostrikis LG, Network C. Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol. 2009;81(2):238-248.
  10. Kurbanov F, Tanaka Y, Chub E, Maruyama I, Azlarova A, Kamitsukasa H, et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis. 2008;198(10):1448-1456.
  11. Moreau I, Hegarty S, Levis J, Sheehy P, Crosbie O, Kenny-Walsh E, et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J. 2006;3:95. doi: 10.1186/1743-422X-3-95
  12. Tallo T, Norder H, Tefanova V, Krispin T, Schmidt J, Ilmoja M, et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol. 2007;79(4):374-382.
  13. Karchava M, Waldenstrom J, Parker M, Hallack R, Sharvadze L, Gatserelia L, et al. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment. Hepatol Res. 2015;45(13):1292-1298.
  14. Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, et al. Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol. 2010;82(2):232-238.
  15. Morel V, Descamps V, François C, Fournier C, Brochot E, Capron D, et al. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed hepatitis C infection: a case report. J Clin Virol. 2010;47(4):382-386.
  16. Susser S, Dietz J, Schlevogt B, Zuckerman E, Barak M, Piazzolla V, et al. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras. Journal of Hepatology. 2017;67(4):680-686.
  17. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol. 2006;80(15):7569-7577.
  18. Kageyama S, Agdamag DM, Alesna ET, Leaño PS, Heredia AML, Abellanosa-Tac-An IP, et al. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol. 2006;78(11):1423-1428.
  19. Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol. 2007;81(8):4357-4362.
  20. Lee Y-M, Lin H-J, Chen Y-J, Lee C-M, Wang S-F, Chang K-Y, et al. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form 2b6w. J Med Virol. 2010;82(1):57-68.
  21. Bhattacharya D, Accola MA, Ansari IH, Striker R, Rehrauer WM. Naturally occurring genotype 2b/1a hepatitis C virus in the United States. Virol J. 2011;8:458-469.
  22. Hedskog C, Doehle B, Chodavarapu K, Gontcharova V, Crespo Garcia J, De Knegt R, et al. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Hepatology. 2015;61(2):471-480.
  23. Yokoyama K, Takahashi M, Nishizawa T, Nagashima S, Jirintai S, Yotsumoto S, et al. Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan. Arch Virol. 2011;156(9):1591-1601.
  24. Iles JC, Njouom R, Foupouapouognigni Y, Bonsall D, Bowden R, Trebes A, et al. Characterization of hepatitis C virus recombination in Cameroon by use of nonspecific next-generation sequencing. J Clin Microbiol. 2015;53(10):3155-3164.
  25. Kurbanov F, Tanaka Y, Avazova D, Khan A, Sugauchi F, Kan N, et al. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatology Research. 2007;38(5):457-464.
  26. Kalinina OV, Dudina KR, Kozina AN, Dmitriev AV, Isaguliants MG, Znoiko OO. Hepatitis C virus intergenoptic recombinants: the natural model for studying molecular genetic determinants of viral resistance to antiviral drugs. Translational Medicine. 2014;3(26):29-38. (In Russ.)
  27. Calado RA, Rocha MR, Parreira R, Piedade J, Venenno MT, Esteves A. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. J Med Virol. 2011;83(4):608-615.
  28. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology. 1999;29(1):217-222.
  29. Roque-Afonso AM, Ducoulombier D, Di Liberto G, Kara R, Gigou M, Dussaix E, et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol. 2005;79(10):6349-6357.
  30. Laskus T, Wang LF, Radkowski M, Vargas H, Nowicki M, Wilkinson J, et al. Exposure of Hepatitis C Virus (HCV) RNA-Positive Recipients to HCV RNA-Positive Blood Donors Results in Rapid Predominance of a Single Donor Strain and Exclusion and/or Suppression of the Recipient Strain. J Virol. 2001;75(5):2059-2066.
  31. Gao F, Nainan OV, Khudyakov Y, Li J, Hong Y, Gonzales AC, et al. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol. 2007;88(Pt1):143-147.
  32. Scheel TKH, Galli A, Li Y-P, Mikkelsen LS, Gottwein JM, Bukh J. PLoS Pathog. 2013;9(3):e1003228.
  33. Worobey M, Holmes EC. Evolutionary aspects of recombination in RNA viruses. J Gen Virol. 1999;80(Pt10):2535-2543.
  34. Galli A, Bukh J. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus. Trends in Microbiology. 2014;22(6):354-364.
  35. Kalinina O, Norder H, Magnius LO. Full-length open reading frame of a recombinant hepatitis C virus strain from St. Petersburg: proposed mechanism for its formation. J Gen Virol. 2004;85:1853-1857.
  36. Morel V, Fournier C, François C, Brochot E, Helle F, Duverlie G, et al. J. Genetic recombination of the hepatitis C virus: clinical implications. Viral Hepat. 2011;18(2):77-83.
  37. Austermann-Busch S, Becher P. RNA structural elements determine frequency and sites of nonhomologous recombination in an animal plus-strand RNA virus. J Virol. 2012;86(13):7393-7402.
  38. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
  39. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol. 1997;53(1):36-40.
  40. Lvov DK, Samokhvalov EI, Mishiro S, Tsuda F, Selivanov NA, Okamoto H i dr. Regularities in the prevalence of hepatitis C virus and its genotypes in Russia and the former USSA countries. Problems of Virology. 1997;42(4):157-161. (In Russ.)
  41. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Nesterov AE i dr. Occurance of hepatitis C virus markers and risk factors among hospital personnel in the Novosibirsk region. Zh Microbiol. 2002;2:26-32. (In Russ.)
  42. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Akinfeeva LA i dr. Occurance of markers, distribution of genotypes and risk factors for viral hepatitis C among some gpoups of the population in the Novosibirsk region. Zh Microbiol. 2004;5:20-25. (In Russ.)
  43. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Akinfeeva LA, Rakova IG, et al. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol. 2005;77(3):382-389.
  44. Kochneva GV, Grazhdantseva AA, Sivolobova GF, Shustov AV, Gavrilova IV, Chub EV i dr. Etiology of acute hepatites and genotypic diversity of viruses of hepatites A, B, C, and E in three Siberian regions. Infectious Diseases. 2005;3(1):26-31. (In Russ.)
  45. Mukomolov S, Trifonova G, Levakova I, Bolsun D, Krivanogova E. Hepatitis C in the Russian Federation: challenges and future directions. Hepatic Medicine: Evidence and Research. 2016;8:51-60.
  46. Simmonds P. Genetic diversity and evolution of hepatitis C virus — 15 years on. J Gen Virol. 2004;85(Pt11):3173-3188.
  47. Samokhvalov EI, Hijikata M, Gylka RI, Lvov DK, Mishiro S. Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k). Virus Genes. 2000;20(2):183-187.
  48. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol. 2003;69(3):367-375.
  49. Thomas F, Nicot F, Sandres-Saune K, Dubois M, Legrand-Abravanel F, Alric L, et al. Genetic diversity of HCV genotype 2 strains in south western France. J Med Virol. 2006;79(1):26-34.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.